NCT01421017 2021-11-18
Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases
NYU Langone Health
Phase 1/2 Completed
Clinical Trials
5 trialsNCT03982004 2021-06-21
Epicutaneous Cryoimmunotherapy Combined With Pembrolizumab for Cutaneous Metastatic Breast Cancer
Washington University School of Medicine
Phase 1 Terminated
NCT02276300 2019-11-20
HER2
Technical University of Munich
Phase 1 Completed
NCT00821964 2018-01-02
Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer
University of Washington
Phase 2 Completed
NCT00899574 2015-12-07
Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases
NYU Langone Health
Phase 2 Completed